OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Kenneth Kosik

3 Projects | 1 Researchers | $629,000 Invested

2022

University of California, Santa Barbara

Kenneth Kosik, MD

Discovery of selective LRP1 inhibitors to prevent tau uptake and spread

  • Funding Amount: $300,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Tau
  • Status: Active

2004

Brigham and Women's Hospital

Kenneth Kosik, MD

The Development of CDK5 Inhibitors

  • Funding Amount: $199,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2001

Brigham and Women's Hospital

Kenneth Kosik, MD

Identifying Drugs That Inhibit Kinase-Induced Dissociation of Tau From Microtububles

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed